Clinical Trials Browser

Breast Cancer Early Stage Breast Cancer (Stage 1-3) × fezolinetant × 90 days × Clear all

NCT06917313 2026-02-10

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Phase 2 Recruiting

Breast Cancer Early Stage Breast Cancer (Stage 1-3)